Norway· NO-ID_221C9EF4-4046-4BD9-81A3-914D2FB7CFEE

Debridat

A trimebutine product containing trimebutine, registered in Norway by Pfizer. The same ATC class is registered in 6 of our 19 countries.

ATC A03AA05

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedDebridatATCA03AA05REGISTER NO.NO-ID_221C9EF4-4046-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Trimebutine is registered in 6 of 19 countries.

Countries holding a registration under ATC A03AA05 (trimebutine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 4 of them publish a price we can compare per daily dose

Trimebutine · ATC A03AA05

6 / 19 countries

  • Canada
  • Franceprice
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trimebutine costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Trimebutine · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • FR France$0.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Trimebutine
Manufacturer
Pfizer
Country
Norway (NO)
ATC code
A03AA05
ATC class
Trimebutine
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_221C9EF4-4046-4BD9-81A3-914D2FB7CFEE
  • no_varenummer
    304399
    30
  • gtin
    3400935919410

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trimebutine in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trimebutine products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Bulgaria · Трибутин
  • Spain · Polibutin
  • France · Debricalm, Debridat
  • Greece · Garapepsin, Ibutin
  • Italy · Debridat, Digerent
  • Poland · Debretin, Debretin Forte
  • Portugal · Debridat
  • Romania · Colperin, Debridat

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/69fca5b6-715d-4e9a-a82d-cb51c89c1aea
GET /v1/drugs/69fca5b6-715d-4e9a-a82d-cb51c89c1aea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Trimebutin",
  "merkevare_id": "ID_221C9EF4-4046-4BD9-81A3-914D2FB7CFEE",
  "name_form_strength": "Debridat tab 200 mg",
  "prescription_group": "C"
}

See everything about trimebutine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.